Clearpoint Neuro Inc share price today

(CLPT)

Clearpoint Neuro Inc share price is $12.24 & ₹1,036.54

$12.24

▲

-0.13

(-1.05%)

Market is closed - opens 8 PM, 03 Dec 2024

View live Clearpoint Neuro Inc share price in Dollar and Rupees. Guide to invest in Clearpoint Neuro Inc from India. Also see the sentimental analysis on Indian investors investing in Clearpoint Neuro Inc. Get details on the Indian mutual funds that are investing in Clearpoint Neuro Inc. Get Analyst recommendations and forecasts along with all the Clearpoint Neuro Inc's financials.

Clearpoint Neuro Inc share price movements

$12.18
$12.58
$12.24
0.49%
Downside
Day's Volatility :3.18%
Upside
2.7%
$5.11
$14.13
$12.24
58.29%
Downside
52 Weeks Volatility :63.86%
Upside
13.35%

Clearpoint Neuro Inc Returns

Period	Clearpoint Neuro Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-3.01%	-6.2%	0.0%
6 Months	118.96%	1.7%	0.0%
1 Year	100.66%	11.6%	0.0%
3 Years	-1.69%	12.9%	-18.1%

Clearpoint Neuro Inc Key Statistics

in dollars & INR

Market Capitalization	$341.2M
Revenue TTM	$30.4M
EBITDA	$-17.9M
Earnings Per Share (EPS)	$-0.69
Profit Margin	-59.64%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-68.36%

How to invest in Clearpoint Neuro Inc from India?

It is very easy for Indian residents to invest directly in Clearpoint Neuro Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Clearpoint Neuro Inc stock in both rupees (INR) and dollars (USD). Search for Clearpoint Neuro Inc or CLPT on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Clearpoint Neuro Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Clearpoint Neuro Inc shares which would translate to 0.069 fractional shares of Clearpoint Neuro Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Clearpoint Neuro Inc

-8%

Period: Sep 3, 2024 to Dec 2, 2024. Change in 30 Days versus previous period

Search volume for Clearpoint Neuro Inc on INDmoney from India has reduced in the last 30 days as on Dec 3, 2024. -8% less investors are searching Clearpoint Neuro Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Clearpoint Neuro Inc

Vanguard Group Inc
4.51%
Essex Investment Management Company, LLC
1.68%
Taylor Frigon Capital Management LLC
1.36%
BlackRock Inc
1.33%
Brown Advisory Holdings Inc
1.21%
CM Management, LLC
1.09%

Analyst Recommendation on Clearpoint Neuro Inc

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Clearpoint Neuro Inc(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Clearpoint Neuro Inc

What analysts predicted

Upside of 33.44%

Current:

$12.24

Target:

$16.33

Insights on Clearpoint Neuro Inc

Increasing Revenue
Revenue is up for the last 5 quarters, 5.76M → 8.12M (in $), with an average increase of 8.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -4.14M → -4.97M (in $), with an average decrease of 9.6% per quarter
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 129.2% return, outperforming this stock by 129.2%

Clearpoint Neuro Inc Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$7.4M	↓ 0.36%
Net Income	$-6.2M	↓ 14.01%
Net Profit Margin	-83.82%	↑ 13.3%

	FY19	Y/Y Change
Revenue	$11.2M	↑ 52.54%
Net Income	$-6.5M	↑ 5.53%
Net Profit Margin	-57.98%	↑ 25.84%

	FY20	Y/Y Change
Revenue	$12.8M	↑ 14.37%
Net Income	$-9.1M	↑ 40.04%
Net Profit Margin	-71.0%	↓ 13.02%

	FY21	Y/Y Change
Revenue	$16.3M	↑ 27.05%
Net Income	$-15.3M	↑ 68.2%
Net Profit Margin	-93.99%	↓ 22.99%

	FY22	Y/Y Change
Revenue	$20.6M	↑ 26.09%
Net Income	$-16.5M	↑ 7.95%
Net Profit Margin	-80.47%	↑ 13.52%

	FY23	Y/Y Change
Revenue	$24.0M	↑ 16.56%
Net Income	$-22.1M	↑ 33.57%
Net Profit Margin	-92.21%	↓ 11.74%

	Q2 FY23	Q/Q Change
Revenue	$6.0M	↑ 9.52%
Net Income	$-7.1M	↑ 30.79%
Net Profit Margin	-118.52%	↓ 19.27%

	Q3 FY23	Q/Q Change
Revenue	$5.8M	↓ 3.16%
Net Income	$-4.8M	↓ 31.81%
Net Profit Margin	-83.46%	↑ 35.06%

	Q4 FY23	Q/Q Change
Revenue	$6.8M	↑ 18.19%
Net Income	$-4.6M	↓ 3.95%
Net Profit Margin	-67.83%	↑ 15.63%

	Q1 FY24	Q/Q Change
Revenue	$7.6M	↑ 12.17%
Net Income	$-4.1M	↓ 10.24%
Net Profit Margin	-54.27%	↑ 13.56%

	Q2 FY24	Q/Q Change
Revenue	$7.9M	↑ 2.87%
Net Income	$-4.4M	↑ 6.32%
Net Profit Margin	-56.1%	↓ 1.83%

	Q3 FY24	Q/Q Change
Revenue	$8.1M	↑ 3.36%
Net Income	$-5.0M	↑ 12.84%
Net Profit Margin	-61.24%	↓ 5.14%

	FY18	Y/Y Change
Total Assets	$7.9M	↓ 43.47%
Total Liabilities	$6.3M	↓ 21.35%

	FY19	Y/Y Change
Total Assets	$11.9M	↑ 51.8%
Total Liabilities	$7.3M	↑ 15.66%

	FY20	Y/Y Change
Total Assets	$29.6M	↑ 148.52%
Total Liabilities	$27.3M	↑ 271.44%

	FY21	Y/Y Change
Total Assets	$65.6M	↑ 121.26%
Total Liabilities	$16.8M	↓ 38.4%

	FY22	Y/Y Change
Total Assets	$55.5M	↓ 15.39%
Total Liabilities	$18.6M	↑ 10.77%

	FY23	Y/Y Change
Total Assets	$42.7M	↓ 23.12%
Total Liabilities	$21.5M	↑ 15.51%

	Q2 FY23	Q/Q Change
Total Assets	$47.6M	↓ 5.19%
Total Liabilities	$20.2M	↑ 14.51%

	Q3 FY23	Q/Q Change
Total Assets	$43.8M	↓ 7.98%
Total Liabilities	$19.7M	↓ 2.41%

	Q4 FY23	Q/Q Change
Total Assets	$42.7M	↓ 2.68%
Total Liabilities	$21.5M	↑ 8.84%

	Q1 FY24	Q/Q Change
Total Assets	$53.6M	↑ 25.73%
Total Liabilities	$19.1M	↓ 11.33%

	Q2 FY24	Q/Q Change
Total Assets	$52.6M	↓ 1.98%
Total Liabilities	$20.4M	↑ 7.29%

	Q3 FY24	Q/Q Change
Total Assets	$40.2M	↓ 23.55%
Total Liabilities	$11.2M	↓ 45.25%

	FY18	Y/Y Change
Operating Cash Flow	$-4.6M	↓ 22.73%
Investing Cash Flow	$-63.5K	↑ 137.33%
Financing Cash Flow	$-1.5M	↓ 112.46%

	FY19	Y/Y Change
Operating Cash Flow	$-2.8M	↓ 38.46%
Investing Cash Flow	$-160.0K	↑ 152.01%
Financing Cash Flow	$5.6M	↓ 474.97%

	FY20	Y/Y Change
Operating Cash Flow	$-7.8M	↑ 174.01%
Investing Cash Flow	$-482.0K	↑ 201.25%
Financing Cash Flow	$22.7M	↑ 304.92%

	FY21	Y/Y Change
Operating Cash Flow	$-12.7M	↑ 62.62%
Investing Cash Flow	$-168.0K	↓ 65.15%
Financing Cash Flow	$46.9M	↑ 106.56%

	FY22	Y/Y Change
Operating Cash Flow	$-16.2M	↑ 27.33%
Investing Cash Flow	$-10.7M	↑ 6290.48%
Financing Cash Flow	$409.0K	↓ 99.13%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-5.1M	↓ 10.65%
Investing Cash Flow	$9.5M	↓ 6991.3%
Financing Cash Flow	$237.0K	↓ 4840.0%

Clearpoint Neuro Inc Technicals Summary

Sell

Neutral

Buy

Clearpoint Neuro Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Clearpoint Neuro Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Clearpoint Neuro Inc	-3.92%	118.96%	100.66%	-1.69%	-33.69%
Stryker Corporation	6.2%	13.93%	33.92%	53.15%	91.74%
Boston Scientific Corp.	6.74%	19.11%	65.11%	122.19%	109.04%
Edwards Lifesciences Corp.	6.11%	-19.31%	1.95%	-37.0%	-12.91%
Abbott Laboratories	-0.71%	12.94%	11.05%	-11.82%	37.04%
Medtronic Plc	-3.1%	3.93%	8.5%	-21.5%	-22.87%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Clearpoint Neuro Inc	NA	NA	NA	-0.67	-0.68	-0.28	NA	1.05
Stryker Corporation	42.03	42.03	2.74	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	74.93	74.93	1.64	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	27.55	27.55	6.52	2.53	0.19	0.11	NA	16.18
Abbott Laboratories	36.1	36.1	2.31	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	26.38	26.38	1.56	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Clearpoint Neuro Inc	Buy	$341.2M	-33.69%	NA	-59.64%
Stryker Corporation	Buy	$149.5B	91.74%	42.03	16.34%
Boston Scientific Corp.	Buy	$133.7B	109.04%	74.93	11.26%
Edwards Lifesciences Corp.	Buy	$42.5B	-12.91%	27.55	65.86%
Abbott Laboratories	Buy	$206.3B	37.04%	36.1	13.99%
Medtronic Plc	Buy	$110.6B	-22.87%	26.38	12.06%

About Clearpoint Neuro Inc

we are a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or mri, guidance. since our inception in 1998, we have focused on research and product development in the field of interventional mri. from 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling mri-guided interventions and to build an intellectual property position. in 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. we have two product platforms. our clearpoint® system, which is in commercial use in the united states, is used to perform minimally invasive surgical procedures in the brain. our cleartrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. bot

Organization	Clearpoint Neuro Inc
Employees	107
CEO	Mr. Joseph Michael Burnett
Industry	Health Technology

Important FAQs about investing in Clearpoint Neuro Inc from India :

What is Clearpoint Neuro Inc share price today?

Clearpoint Neuro Inc (CLPT) share price today is $12.24.

Can Indians buy Clearpoint Neuro Inc shares?

Yes, Indians can invest in the Clearpoint Neuro Inc (CLPT) from India.

With INDmoney, you can buy Clearpoint Neuro Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Clearpoint Neuro Inc at zero transaction cost.

How can I buy Clearpoint Neuro Inc shares from India?

It is very easy to buy Clearpoint Neuro Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Clearpoint Neuro Inc be purchased?

Yes, you can buy fractional shares of Clearpoint Neuro Inc with INDmoney app.

What are the documents required to start investing in Clearpoint Neuro Inc stocks?

To start investing in Clearpoint Neuro Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.